Jeffrey Farrow
2016 - Global Blood Therapeutics
In 2016, Jeffrey Farrow earned a total compensation of $2M as Chief Financial Officer at Global Blood Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $115,000 |
|---|---|
| Option Awards | $1,613,816 |
| Salary | $298,718 |
| Other | $2,500 |
| Total | $2,030,034 |
Farrow received $1.6M in option awards, accounting for 79% of the total pay in 2016.
Farrow also received $115K in non-equity incentive plan, $298.7K in salary and $2.5K in other compensation.
Rankings
In 2016, Jeffrey Farrow's compensation ranked 4,821st out of 14,075 executives tracked by ExecPay. In other words, Farrow earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,821 out of 14,075 | 66th |
Division Manufacturing | 1,717 out of 5,486 | 69th |
Major group Chemicals And Allied Products | 534 out of 1,900 | 72nd |
Industry group Drugs | 394 out of 1,543 | 75th |
Industry Pharmaceutical Preparations | 312 out of 1,173 | 73rd |
Source: SEC filing on April 28, 2017.
Farrow's colleagues
We found three more compensation records of executives who worked with Jeffrey Farrow at Global Blood Therapeutics in 2016.